SCHEMBL16013141

SCHEMBL16013141

CCCCCCC(=O)CC(C)(O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.54
MAPT P10636 1/20 0.54
CES2 O00748 4/20 0.50
CES1 P23141 4/20 0.50
HAO1 Q9UJM8 1/20 0.48
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 7/20 0.48
PPARD Q03181 7/20 0.48
PPARA Q07869 7/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 4/20 0.48
PTPN1 P18031 3/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48
MEN1 O00255 1/20 0.48
ESR1 P03372 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19617979 0.84 KMT2A (0.56) KMT2AMAPTCES2CES1HAO1
SCHEMBL96402 0.84 KMT2A (0.50) KMT2AMAPTCES2CES1HAO1
SCHEMBL8897012 0.84 KMT2A (0.56) KMT2AMAPTCES2CES1HAO1
SCHEMBL29229899 0.84 KMT2A (0.56) KMT2AMAPTCES2CES1HAO1
SCHEMBL11038929 0.84 KMT2A (0.56) KMT2AMAPTCES2CES1HAO1
SCHEMBL2994225 0.84 KMT2A (0.56) KMT2AMAPTCES2CES1HAO1
SCHEMBL4451253 0.84 KMT2A (0.56) KMT2AMAPTCES2CES1HAO1
SCHEMBL15393198 0.84 KMT2A (0.56) KMT2AMAPTCES2CES1HAO1
SCHEMBL30467239 0.83 KMT2A (0.50) KMT2AMAPTCES2CES1HAO1
SCHEMBL27971770 0.83 KMT2A (0.50) KMT2AMAPTCES2CES1HAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12396941-B2 Cosmetic composition that resists pilling L'OREAL (FR) 2025-08-26 US claimed
US-11819559-B2 Cosmetic compositions comprising an antimicrobial system with reduced eye irritation or discomfort L'OREAL (FR) 2023-11-21 US claimed
EP-4221665-A1 COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT L'OREAL (FR) 2023-08-09 EP claimed
CN-116367810-A Cosmetic composition comprising an antimicrobial system for reducing eye irritation or discomfort 欧莱雅 2023-06-30 CN claimed
US-11679072-B2 Water-based smudge-resistant make-up remover L'OREAL (FR) 2023-06-20 US claimed
WO-2022072585-A1 COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT L'OREAL (FR) 2022-04-07 WO claimed
US-20220096345-A1 COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT L'OREAL (FR) 2022-03-31 US claimed
WO-2022047179-A1 WATER-BASED SMUDGE-RESISTANT MAKE-UP REMOVER L'OREAL (FR) 2022-03-03 WO claimed
US-20220062150-A1 WATER-BASED SMUDGE-RESISTANT MAKE-UP REMOVER L'OREAL (FR) 2022-03-03 US claimed
US-10638755-B2 Antimicrobial compositions SYMRISE AG (DE) 2020-05-05 US claimed
US-20160015031-A1 Antimicrobial Compositions SYMRISE AG (DE) 2016-01-21 US claimed
WO-2014135650-A1 ANTIMICROBIAL COMPOSITIONS SYMRISE AG (DE) 2014-09-12 WO claimed
EP-4746843-A1 NATURE-BASED FACIAL LIFTING MASK L'OREAL (FR) 2026-05-27 EP disclosed
US-20260115114-A1 COSMETIC COMPOSITION THAT RESISTS PILLING L'OREAL (FR) 2026-04-30 US disclosed
US-20260102323-A1 STABLE COSMETIC COMPOSITION WITH HIGH LEVEL OF ELECTROLYTES L'OREAL (FR) 2026-04-16 US disclosed
US-12582584-B2 Oxidizer and acid based system and regimen for enhancing skin appearance L'OREAL (FR) 2026-03-24 US disclosed
US-20210093530-A1 BIPHASE CHEMICAL PEEL L'OREAL (FR) 2021-04-01 US disclosed
WO-2021062208-A1 BIPHASE CHEMICAL PEEL L'OREAL (FR) 2021-04-01 WO disclosed
WO-2021041312-A1 SILICONE-FREE, LOW-FRICTION CLEANSER WITH HIGH-FOAMING PROPERTIES L'OREAL (FR) 2021-03-04 WO disclosed
US-20210059921-A1 SILICONE-FREE, LOW-FRICTION CLEANSER WITH HIGH-FOAMING PROPERTIES L'OREAL (FR) 2021-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12582584-B2 Oxidizer and acid based system and regimen for enhancing skin appearance CUTA, PLOD2, HAO2 KMT2A 3277/4885MAPT 4818/4885CES2 1335/4885
US-10638755-B2 Antimicrobial compositions CUTA, ARG1, POLR1C KMT2A 2113/4885MAPT 4444/4885CES2 4043/4885
US-20220096345-A1 COSMETIC COMPOSITIONS COMPRISING AN ANTIMICROBIAL SYSTEM WITH REDUCED EYE IRRITATION OR DISCOMFORT GK, PIR, LAGE3 KMT2A 3551/4885MAPT 4303/4885CES2 2582/4885
US-11819559-B2 Cosmetic compositions comprising an antimicrobial system with reduced eye irritation or discomfort GK, PIR, LAGE3 KMT2A 3551/4885MAPT 4303/4885CES2 2582/4885
US-20260102323-A1 STABLE COSMETIC COMPOSITION WITH HIGH LEVEL OF ELECTROLYTES PNISR, PRMT1, CUTA KMT2A 101/4885MAPT 2263/4885CES2 4288/4885
US-20260115114-A1 COSMETIC COMPOSITION THAT RESISTS PILLING CUTA, COL2A1, LIPA KMT2A 1923/4885MAPT 2403/4885CES2 2838/4885
US-20160015031-A1 Antimicrobial Compositions CUTA, ARG1, POLR1C KMT2A 2113/4885MAPT 4444/4885CES2 4043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.